RNS Number : 6402W
Legal & General UCITS ETF PLC
19 August 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
19/08/2020 |
IE00BFXR5Q31 |
13147267 |
USD |
168041558.21 |
12.781 |
| L&G UK Equity UCITS ETF |
19/08/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10886613.00 |
9.072 |
| L&G Global Equity UCITS ETF |
19/08/2020 |
IE00BFXR5S54 |
2900000 |
USD |
35473487.75 |
12.232 |
| L&G Japan Equity UCITS ETF |
19/08/2020 |
IE00BFXR5T61 |
11185000 |
USD |
123458713.82 |
11.038 |
| L&G Europe ex UK Equity UCITS ETF |
19/08/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
103184823.35 |
11.023 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
19/08/2020 |
IE00BFXR5W90 |
5381427 |
USD |
59337686.27 |
11.026 |
| L&G Clean Water UCITS ETF |
19/08/2020 |
IE00BK5BC891 |
1650000 |
USD |
18917674.23 |
11.465 |
| L&G Artificial Intelligence UCITS ETF |
19/08/2020 |
IE00BK5BCD43 |
7946000 |
USD |
111562346.79 |
14.040 |
| L&G Healthcare Innovation UCITS ETF |
19/08/2020 |
IE00BK5BC677 |
3200000 |
USD |
45072964.32 |
14.085 |
| L&G Pharma Breakthrough UCITS ETF |
19/08/2020 |
IE00BF0H7608 |
2000000 |
USD |
25207668.81 |
12.604 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
19/08/2020 |
IE00BKLTRN76 |
9600000 |
EUR |
99970978.60 |
10.414 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
19/08/2020 |
IE00BKLWY790 |
57800000 |
USD |
666958242.96 |
11.539 |
| L&G Battery Value-Chain UCITS ETF |
19/08/2020 |
IE00BF0M2Z96 |
14500000 |
USD |
159045437.95 |
10.969 |
| L&G Ecommerce Logistics UCITS ETF |
19/08/2020 |
IE00BF0M6N54 |
9750000 |
USD |
119147393.32 |
12.220 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
19/08/2020 |
IE00BMW3QX54 |
46130616 |
USD |
872979638.14 |
18.924 |
| L&G Cyber Security UCITS ETF |
19/08/2020 |
IE00BYPLS672 |
84356776 |
USD |
1684171719.02 |
19.965 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVDZGMRZLZGGZZ
